PD13-01 LOSS OF FOXA1 EXPRESSION IS ASSOCIATED WITH ADVERSE PATHOLOGIC FEATURES AND INFERIOR ONCOLOGIC OUTCOMES FOLLOWING RADICAL NEPHROURETERECTOMY
Lauren Shuman
,
Joshua Warrick
,
David Degraff
,
Shahrokh Shariat
,
Jose Karam
,
Christopher Wood
(1)
,
Alon Weizer
(2)
,
Mesut Remzi
(3)
,
Andrea Haitel
(4)
,
Karim Bensalah
(5, 6)
,
Nathalie Rioux-Leclercq
(7)
,
Christian Bolenz
(8)
,
Marco Roscigno
,
Laura-Maria Krabbe
(9)
,
Payal Kapur
(9)
,
Yair Lotan
(9)
,
Vitaly Margulis
(9)
,
Jay Raman
(10)
1
MD Anderson Cancer Center
2 University of Michigan [Ann Arbor]
3 Department of Urology
4 Medizinische Universität Wien = Medical University of Vienna
5 Service d'urologie [Rennes] = Urology [Rennes]
6 LTSI - Laboratoire Traitement du Signal et de l'Image
7 IGDR - Institut de Génétique et Développement de Rennes
8 Mannheim Medical Center
9 Department of Urology
10 Department of Urologic Oncology
2 University of Michigan [Ann Arbor]
3 Department of Urology
4 Medizinische Universität Wien = Medical University of Vienna
5 Service d'urologie [Rennes] = Urology [Rennes]
6 LTSI - Laboratoire Traitement du Signal et de l'Image
7 IGDR - Institut de Génétique et Développement de Rennes
8 Mannheim Medical Center
9 Department of Urology
10 Department of Urologic Oncology
Lauren Shuman
- Function : Author
Joshua Warrick
- Function : Author
David Degraff
- Function : Author
Shahrokh Shariat
- Function : Author
Jose Karam
- Function : Author
Marco Roscigno
- Function : Author
Abstract
no abstract